Ultragenyx Pharmaceutical, Inc. (RARE)
23.88
-0.82
(-3.32%)
USD |
NASDAQ |
Feb 09, 16:00
23.80
-0.08
(-0.34%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Total Assets (Quarterly) : 1.190B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 823.61M |
| Johnson & Johnson | -- |
| CorMedix, Inc. | 750.86M |
| Insmed, Inc. | 2.361B |
| Apellis Pharmaceuticals, Inc. | 1.059B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.174B |
| Shareholders Equity (Quarterly) | 9.159M |
| Debt to Equity Ratio | 94.24 |
| Current Ratio | 1.892 |
| Net Debt Paydown Yield | 0.44% |